Janux commences Phase Ib studies in trial for prostate cancer treatment

Janux commences Phase Ib studies in trial for prostate cancer treatment

Submitted by admin on May 6, 2025 - 10:31am
Source: 
Clinical Trials Arena
News Tags: 
Janux Therapeutics
JANX007
clinical trials
prostate cancer
metastatic castration-resistant prostate cancer
Headline: 
Janux commences Phase Ib studies in trial for prostate cancer treatment
snippet: 

Janux Therapeutics has started Phase Ib expansion trials with JANX007 in the first-in-human ENGAGER-PSMA-01 clinical trial, aimed at treating advanced metastatic castration-resistant prostate cancer (mCRPC).

Do Not Allow Advertisers to Use My Personal information